Trump drug price plan could nix investment, warns Roche / Photo: SEBASTIEN BOZON - AFP
-
Iran boxer sentenced to death at 'imminent' risk of execution: rights groups
-
Snicko operator admits error that led to Carey's Ashes reprieve
-
Finland PM apologises to Asian countries over MPs' mocking posts
-
Doctors in England go on strike for 14th time
-
Romania journalists back media outlet that sparked graft protests
-
Rob Reiner's son awaiting court appearance on murder charges
-
Ghana's Highlife finds its rhythm on UNESCO world stage
-
Stocks gain as traders bet on interest rate moves
-
France probes 'foreign interference' after malware found on ferry
-
Europe's Ariane 6 rocket puts EU navigation satellites in orbit
-
Bleak end to the year as German business morale drops
-
Hundreds queue at Louvre museum as strike vote delays opening
-
Bondi shooting shocks, angers Australia's Jewish community
-
Markets rise even as US jobs data fail to boost rate cut bets
-
Senegal talisman Mane overcame grief to become an African icon
-
Carey pays tribute to late father after home Ashes century
-
'Many lessons to be learned' from Winter Games preparations, says ski chief
-
Emotional Carey slams ton to give Australia upper hand in 3rd Ashes Test
-
Asian markets mixed as US jobs data fails to boost rate cut hopes
-
Carey slams ton as Australia seize upper hand in third Ashes Test
-
Bondi shooting shocks, angers Australia Jewish community
-
Myanmar junta seeks to prosecute hundreds for election 'disruption'
-
West Indies hope Christmas comes early in must-win New Zealand Test
-
Knicks beat Spurs in NBA Cup final to end 52-year trophy drought
-
Khawaja revels in late lifeline as Australia 194-5 in 3rd Ashes Test
-
Grief and fear as Sydney's Jewish community mourns 'Bondi rabbi'
-
Trump orders blockade of 'sanctioned' Venezuela oil tankers
-
Brazil Senate to debate bill to slash Bolsonaro jail term
-
New Zealand ex-top cop avoids jail time for child abuse, bestiality offences
-
Eurovision facing fractious 2026 as unity unravels
-
'Extremely exciting': the ice cores that could help save glaciers
-
Asian markets drift as US jobs data fails to boost rate cut hopes
-
What we know about Trump's $10 billion BBC lawsuit
-
Ukraine's lost generation caught in 'eternal lockdown'
-
'Catastrophic mismatch': Safety fears as Jake Paul faces Anthony Joshua
-
Australia's Steve Smith ruled out of third Ashes Test
-
Khawaja grabs lifeline as Australia reach 94-2 in 3rd Ashes Test
-
Undefeated boxing great Crawford announces retirement
-
Trump says orders blockade of 'sanctioned' Venezuela oil tankers
-
UK experiences sunniest year on record
-
Australia holds first funeral for Bondi Beach attack victims
-
FIFA announces $60 World Cup tickets after pricing backlash
-
Maresca relishes support of Chelsea fans after difficult week
-
Players pay tribute to Bondi victims at Ashes Test
-
Costa Rican president survives second Congress immunity vote
-
Married couple lauded for effort to thwart Bondi Beach shootings
-
Australia holds first funerals for Bondi Beach attack victims
-
Trump has 'alcoholic's personality,' chief of staff says in bombshell interview
-
Rob Reiner killing: son to be charged with double murder
-
Chelsea battle into League Cup semis to ease pressure on Maresca
NYSE - LSE
Trump drug price plan could nix investment, warns Roche
President Donald Trump's plans to dramatically slash drug prices for Americans could make Swiss pharmaceutical giant Roche cancel major investments in the United States, it said Wednesday.
Trump signed an executive order Monday aimed at bringing down the notoriously high prescription drug prices paid by US consumers, news that rattled pharmaceutical companies.
Swiss newspaper NZZ reported Trump's move could lead Roche to reassess plans it announced just last month to invest $50 billion in the United States over five years.
Roche, the world leader in cancer treatments, said in a statement it did not expect Trump's new drugs policy to hurt its business in 2025.
"However, should the proposed EO (executive order) go into effect, Roche's ability to fund the significant investments previously announced in the US will be in question," it said.
Trump has been pushing foreign firms to invest more in the United States, saying the way to avoid his tariff assault on foreign-made goods is to produce them on US soil instead.
Prescription drugs were not targeted in Trump's "Liberation Day" tariff announcements.
Still, Roche appeared to take heed with its April investment announcement, which came just after fellow Swiss rival Novartis said it would increase investment in the United States by $23 billion over five years.
The United States is a key market for Roche, accounting for more than half its pharmaceutical division's revenues.
Roche's US subsidiary Genentech announced a $700-million project Monday to build a new plant in North Carolina, which it says would employ 400 people.
A.Motta--PC
